As a developer, manufacturer, and supplier of noninvasive medical devices, Biopromin LTD is dedicated to delivering high-quality, richly featured medical products making healthcare more accessible and affordable around the world. Since founded in 2011, Biopromin LTD has been striving not only to provide medical devices and industry solutions but also practice corporate value into every aspect of the company. To better serve clients, Biopromin LTD follows the most stringent international and CE manufacturing and quality control standards in each of its state-of-the-art manufacturing facilities, ensuring efficiency and traceability throughout the entire process.
This White Paper aims to provide our clients and stakeholders information to understand the Biopromin LTD privacy policy better. Specifically, this White Paper describes how Biopromin LTD implements its privacy policy to collect, store, transfer and delete data in the process of product design, manufacture, sales and use.
With the effective date of General Data Protection Regulation (GDPR) of European Union, Biopromin LTD has been taking practical actions to comply with GDPR compliance frameworks. Biopromin LTD is a leading practitioner at the forefront of industry compliance practices all along. In this White Paper, it will help you to understand:
? Biopromin's LTD overall privacy protection policy, including guiding principles adopted by Biopromin LTD Headquarters and its subsidiaries; ? Biopromin LTD GDPR compliance programme illustrating the corporate governance and internal controls with regards to the considerations of privacy protection; ? The mechanism of Biopromin's LTD products, including NID (non invasive diagnostic), ESWT (shock-wave therapy), LIT (Low Intensity VHF-UHF therapy) on how to collect, store, transfer and delete data.
Disclaimer:
This White Paper is provided solely for informational purposes and aimed to help existing and prospective business partners understand how Biopromin LTD may facilitate your compliance with the GDPR. It shall not be construed or used as legal advice about the GDPR, its implementing rules or regulatory guidelines. The White Paper summarises Biopromin's LTD GDPR compliance measures and status as of the release date of this document and is subject to future changes without prior notice. As each business partner may have substantially different demands and may be operating under different personal data protection regimes, Biopromin LTD strongly encourages you to transmit that data to another controller without hindrance from the controller to which the personal data has been provided...
a) For software USPIH:
The USPIH software allows you to export data from the results of a patient examination to a paper medium and files of the HTML or PDF format. This enables you to realize the right to data portability.
b) For the KOLIBRI software:
The KOLIBRI software allows you to export data from the results of a patient examination onto paper and PDF files with the subsequent transfer of files via email. This enables you to realize the right to data portability.
The KOLIBRI software allows you to remotely connect the transfer of the results of your research to the doctor's cloud account and the function of displaying the test results in the doctor's account in real-time is implemented.
This allows you to realize the right to data portability.